Omega 3 may not improve CV health

Daily omega 3 supplementation may not reduce risk for cardiovascular (CV) events in high-risk patients, show study findings.

Taking 1 g of the supplement each day did not prevent death or any CV outcome in patients with diabetes, impaired glucose control, or impaired fasting glucose who were at an increased risk for CV events.

The findings contradict those of studies reporting reduced rates of fatal and nonfatal CV events with omega-3 fatty acid supplementation, say the investigators.

The team reports that among 12,513 participants (aged a mean of 64 years) from the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial, deaths from CV causes occurred in 574 (9.1%) patients on the omega 3 regimen, compared with 581 (9.3%) of those patients taking placebo.

The supplement also did not influence major vascular events, death from any cause, or death from arrhythmia, which occurred in 16.5% versus 16.3%, 15.1% versus 15.4%, and 4.6% versus 4.1% of the patients in the omega 3 compared with placebo patients.

There were no significant between-group differences in lipid fractions apart from in mean triglyceride level, which fell by 14.5 mg/dL more with omega 3 supplementation than it did in the placebo group.

No other significant differences in levels of plasma glucose, glycated hemoglobin, blood pressure, or heart rate were observed.

The team remarks in the New England Journal of Medicine that, until now, no large trials have focused on the effect of omega-3 fatty acids in patients with Type 2 diabetes, impaired fasting glucose, or impaired glucose tolerance despite such patients being at increased risk for CV events.

"Whether similar results would have been observed at higher doses is unknown," say the authors, but three other large trials are currently underway that will provide important information about the effect of omega 3 supplementation in people at various risk levels.

The researchers point out that their findings may not be relevant to dietary recommendations to consume more fish, because dietary change not only increases the intake of foods containing omega 3 fatty acids but is also associated with a reduction in the consumption of foods such as red meats, which may be harmful.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2018, August 23). Omega 3 may not improve CV health. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20120620/Omega-3-may-not-improve-CV-health.aspx.

  • MLA

    Robertson, Sally. "Omega 3 may not improve CV health". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20120620/Omega-3-may-not-improve-CV-health.aspx>.

  • Chicago

    Robertson, Sally. "Omega 3 may not improve CV health". News-Medical. https://www.news-medical.net/news/20120620/Omega-3-may-not-improve-CV-health.aspx. (accessed November 22, 2024).

  • Harvard

    Robertson, Sally. 2018. Omega 3 may not improve CV health. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20120620/Omega-3-may-not-improve-CV-health.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes rates skyrocket globally with millions left untreated